Verdad Advisers »

Contineum Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 86k 13.06

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Henderson Group
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Millennium Management
Baker Bros. Advisors
RA Capital Management
Perceptive Advisors
Vanguard Capital Management
FMR
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Longaeva Partners
Sectoral Asset Management

View all funds holding Contineum Therapeutics